API Supplier To Pay $21.75M Over Alleged False, Inflated AWPs

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Supplier of APIs for Compound Rxs To Pay $21.75M To Settle Allegations of Setting False, Inflated AWPs

Dennis Tosh

November 6, 2024 at 01:01 PM EST

A supplier of pharmacy compounding products has agreed to pay $21.75 million to resolve allegations that it reported to the federal government false and inflated average wholesale prices (AWPs) for two ingredients used in compounded prescriptions, causing pharmacies that purchased the ingredients to submit false prescription claims to federal health care programs (United State... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Supplier of APIs for Compound Rxs To Pay $21.75M To Settle Allegations of Setting False, Inflated AWPs

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT